News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Bay
SpineGuard Reports Over 1,000 PediGuard(R) Units Sold in 2Q 2010, a 125% Increase Compared to 2Q 2009
July 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN FRANCISCO and PARIS--(BUSINESS WIRE)--SpineGuard, a privately held company based in San Francisco and Paris, announced today that PediGuard units sold in the second quarter of 2010 increased by 125% compared to the same period in 2009.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Earnings
Lilly Faces Triple Threat of Drug Pricing Pressure as CEO Emphasizes Value
August 7, 2025
·
3 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH CRESSET
From Chat Bots to World Order: The Race for the 21st Century’s Operating System
August 7, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH IQVIA
We Don’t Own Patient Data–We’re Just Babysitting It
July 31, 2025
·
1 min read
·
Lori Ellis
Regulatory
Sarepta Fallout Continues With EU’s Negative Opinion of Elevidys in Ambulatory Patients
July 25, 2025
·
2 min read
·
Tristan Manalac
